Serum IL-13 Levels Are Lower In Patients With Bullous Pemphigoid Compared To Healthy Controls, Research Suggests

HCPlive (7/15, Smith) reports research found “that while serum interleukin (IL)-13 levels are lower in patients with bullous pemphigoid compared to healthy controls, suggesting IL-13 maintains a complex role in disease pathogenesis, IL-13 levels do not correlate with bullous pemphigoid severity or prognosis.” The researchers said, “With the emergence of anti-IL13 biologics, our findings emphasize the need for further research into IL-13’s role in [bullous pemphigoid] pathogenesis and treatment, towards the development of future personalized approaches in [bullous pemphigoid] management.” The findings were published in the Journal of Investigative Dermatology.